NDAORALCONCENTRATE
Approved
Apr 1965
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
PERMITIL (fluphenazine hydrochloride) by Merck & Co. is clinical pharmacology fluphenazine hydrochloride has activity at all levels of the central nervous system as well as on multiple organ systems. Approved for the management of manifestations of psychotic disorders. First approved in 1965.
Drug data last refreshed Yesterday · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PERMITIL (fluphenazine hydrochloride) is an oral antipsychotic concentrate approved in 1965 for managing psychotic disorder manifestations. It exerts therapeutic effects through activity across multiple CNS levels and organ systems, though its precise mechanism of action remains unknown. This first-generation typical antipsychotic represents a foundational therapy in the treatment of schizophrenia and related conditions.
LOE Approaching
As a legacy product approaching loss of exclusivity with moderate competitive pressure (30), brand teams focus on defensive positioning and generic transition planning rather than expansion.
Mechanism of Action
CLINICAL PHARMACOLOGY Fluphenazine hydrochloride has activity at all levels of the central nervous system as well as on multiple organ systems. The mechanism whereby its therapeutic action is exerted is unknown.
Indications (1)
Career Relevance
Working on PERMITIL in a LOE-approaching environment offers limited brand-building opportunities but strong experience in defensive market strategies, generic transition planning, and managed care negotiation. Career value lies in executing mature-product excellence and stakeholder management rather than pioneering new therapies.
Worked on PERMITIL at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.